source
- Merck KGaA sells its CDMO business and US sites to LonzaMerck KGaA announced it will divest its contract development and manufacturing organization (CDMO) operations, transferring ownership of five U.S. manufacturing facilities to Lonza. The transactio…
- Pfizer drops phase 2 pulmonary arterial hypertension candidate amid pipeline cutPfizer has discontinued its phase 2 pulmonary arterial hypertension (PAH) program, PF-07868489, citing business reasons rather than safety or efficacy concerns. The drug, which targets BMP9 inhibi…